Table 3 Clinical information of patients included in WB and IHC
From: Quantitative proteomics identified circulating biomarkers in lung adenocarcinoma diagnosis
Variable | WB | IHC | ||
|---|---|---|---|---|
LUAD (n = 14) | Control (n = 10) | LUAD (n = 10) | Control (n = 12) | |
Age (year) | 65.6 ± 8.7 | 83.5 ± 9.4 | 59.7 ± 7.1 | 58.2 ± 13.4 |
Gender; n (%) | ||||
 Male | 5 (36%) | 5 (50%) | 5 (50%) | 6 (50%) |
 Female | 9 (64%) | 5 (50%) | 5 (50%) | 6 (50%) |
Stage; n (%) | ||||
 I | 11 (78%) |  | 4 (40%) | 2 (16.7%) |
 II | 3 (22%) |  | 2 (20%) | 5 (41.7%) |
 III |  |  | 2 (20%) | 4 (33.3%) |
 IV |  |  | 2 (20%) | 1 (8.3%) |